They re-arm the immune system which deteriorates as we age preventing some cancers from escaping as they usually do. They also act as a benign chemotherapy without any of the usual side effects with evidence pointing to killing pre-cancerous cells which must be replicated.
Used in combination with traditional methods of cancer treatment,there is a dramatic drop in side effects of chemotherapy and radiotherapy with increased and prolonged remissions that demand immediate methodologically sound research.
Just one bioactive compound has taken up 25% of Japanese Government spending on all anti-cancer agents for over 30 years. We must all re-arm our immune systems now and consider pre-emptive use as the first step towards cancer immunization....Continua